EE200100044A - Heterotsüklilised ühendid kui rotamaasensüümide inhibiitorid - Google Patents

Heterotsüklilised ühendid kui rotamaasensüümide inhibiitorid

Info

Publication number: EE200100044A
Authority: EE; Estonia
Prior art keywords: inhibitors; heterocyclic compounds; rotamase enzymes; rotamase; enzymes
Prior art date: 1998-07-21

Application number

EEP200100044A

Other languages

English (en)

Estonian (et)

Inventor

Ian Kemp Mark

James Wythes Martin

John Palmer Michael

Allen Sanner Mark

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-21

Filing date

1999-06-28

Publication date

2002-06-17

1999-06-28 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-06-17 Publication of EE200100044A publication Critical patent/EE200100044A/xx

Links

102000004190 Enzymes Human genes 0.000 title 1
108090000790 Enzymes Proteins 0.000 title 1
101710103508 FK506-binding protein Proteins 0.000 title 1
101710104425 FK506-binding protein 2 Proteins 0.000 title 1
101710104423 FK506-binding protein 3 Proteins 0.000 title 1
101710104333 FK506-binding protein 4 Proteins 0.000 title 1
101710104342 FK506-binding protein 5 Proteins 0.000 title 1
101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 title 1
101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710114693 Outer membrane protein MIP Proteins 0.000 title 1
101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 title 1
101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 title 1
101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 title 1
101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 title 1
101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 title 1
101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 title 1
101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 title 1
101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 title 1
101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 title 1
101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 title 1
101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 title 1
101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 title 1
101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 title 1
102100038809 Peptidyl-prolyl cis-trans isomerase FKBP9 Human genes 0.000 title 1
101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 title 1
101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 title 1
101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 title 1
101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 title 1
101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 title 1
101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 title 1
101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 title 1
150000002391 heterocyclic compounds Chemical class 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

EEP200100044A 1998-07-21 1999-06-28 Heterotsüklilised ühendid kui rotamaasensüümide inhibiitorid EE200100044A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815880.1A GB9815880D0 (en)	1998-07-21	1998-07-21	Heterocycles
PCT/IB1999/001211 WO2000005232A1 (fr)	1998-07-21	1999-06-28	Composes heterocycliques inhibiteurs d'enzymes rotamase

Publications (1)

Publication Number	Publication Date
EE200100044A true EE200100044A (et)	2002-06-17

Family

ID=10835920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100044A EE200100044A (et)	1998-07-21	1999-06-28	Heterotsüklilised ühendid kui rotamaasensüümide inhibiitorid

Country Status (45)

Country	Link
US (2)	US6372736B1 (fr)
EP (1)	EP1100797B1 (fr)
JP (2)	JP3795329B2 (fr)
KR (2)	KR100468185B1 (fr)
CN (3)	CN1511837A (fr)
AP (1)	AP2001002046A0 (fr)
AR (1)	AR019427A1 (fr)
AT (1)	ATE233261T1 (fr)
AU (1)	AU765925B2 (fr)
BG (1)	BG105254A (fr)
BR (1)	BR9912330A (fr)
CA (1)	CA2338214C (fr)
CO (1)	CO5080782A1 (fr)
CR (1)	CR6073A (fr)
DE (1)	DE69905582T2 (fr)
DK (1)	DK1100797T3 (fr)
DZ (1)	DZ2851A1 (fr)
EA (1)	EA003513B1 (fr)
EE (1)	EE200100044A (fr)
ES (1)	ES2191484T3 (fr)
GB (1)	GB9815880D0 (fr)
GE (1)	GEP20033028B (fr)
GT (1)	GT199900115A (fr)
HK (1)	HK1039779A1 (fr)
HN (1)	HN1999000106A (fr)
HR (1)	HRP20010052A2 (fr)
HU (1)	HUP0103413A3 (fr)
ID (1)	ID26991A (fr)
IL (1)	IL140244A0 (fr)
IS (1)	IS5790A (fr)
MA (1)	MA24936A1 (fr)
MY (1)	MY118222A (fr)
NO (1)	NO20010322L (fr)
NZ (2)	NZ522270A (fr)
OA (1)	OA11585A (fr)
PA (1)	PA8478501A1 (fr)
PE (1)	PE20001037A1 (fr)
PL (1)	PL345734A1 (fr)
SI (1)	SI1100797T1 (fr)
SK (1)	SK772001A3 (fr)
SV (1)	SV1999000102A (fr)
TN (1)	TNSN99147A1 (fr)
TR (1)	TR200100135T2 (fr)
TW (1)	TWI229672B (fr)
WO (1)	WO2000005232A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9815696D0 (en) *	1998-07-20	1998-09-16	Pfizer Ltd	Heterocyclics
GB9815880D0 (en) *	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles
ES2234318T3 (es)	1998-11-03	2005-06-16	ABBOTT GMBH & CO. KG	2-fenil-benzimidazoles sustituidos, su preparacion y uso.
DOP2000000107A (es)	1999-12-01	2002-09-16	Agouron Pharmaceutical Inc	Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas
FR2805818B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DE10124953A1 (de) *	2001-05-21	2002-12-12	Marlies Knipper	Substanz für die therapeutische Behandlung von Tinnitus
EP1778637B1 (fr) *	2004-06-29	2012-02-22	Aventis Pharmaceuticals Inc.	Composition de liaison aux protéines FKBP et utilisation pharmaceutique associée
US7728026B2 (en) *	2005-04-11	2010-06-01	Abbott Laboratories, Inc.	2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
TWI375673B (en) *	2005-04-11	2012-11-01	Abbott Lab	1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
WO2007041357A1 (fr) *	2005-09-29	2007-04-12	Abbott Laboratories	1h-benzimidazole-4-carboxamides a substitution phenyle en position 2, utilises comme inhibiteurs de la parp
ATE461923T1 (de) *	2005-11-15	2010-04-15	Abbott Lab	Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
PL1976828T3 (pl)	2005-12-29	2017-07-31	Celtaxsys, Inc.	Pochodne diaminy jako inhibitory hydrolazy leukotrienu a4
RU2462458C2 (ru) *	2006-02-10	2012-09-27	Байомарин Ига Лимитед	Лечение миодистрофии дюшена
GB0602768D0 (en) *	2006-02-10	2006-03-22	Vastox Plc	Treatment of muscular dystrophy
KR101472248B1 (ko)	2006-02-10	2014-12-16	서미트 코포레이션 피엘씨	뒤시엔느 근이영양증의 치료
ES2385849T3 (es) *	2006-05-02	2012-08-01	Abbott Laboratories	Las 1H-bencimidazol-4-carboxamidas substituidas son potentes inhibidores de la PARP
US8338455B2 (en)	2006-12-20	2012-12-25	Amgen Inc.	Compounds and methods of use
CL2008000666A1 (es) *	2007-03-07	2008-06-13	Xenon Pharmaceuticals Inc	Compuestos derivados de triciclos sustituidos, inhibidores del transportador de metales divalentes-1; y uso para tratar una enfermedad asociada con un trastorno del hierro.
US8067613B2 (en) *	2007-07-16	2011-11-29	Abbott Laboratories	Benzimidazole poly(ADP ribose)polymerase inhibitors
PE20090510A1 (es) *	2007-08-03	2009-05-22	Summit Corp Plc	Combinaciones de drogas para el tratamiento de la distrofia muscular de duchenne
GB0715937D0 (en) *	2007-08-15	2007-09-26	Vastox Plc	Method of treatment og duchenne muscular dystrophy
GB0715939D0 (en) *	2007-08-15	2007-09-26	Vastox Plc	Method of treatment of duchenne muscular dystrophy
DE102008060549A1 (de)	2008-12-04	2010-06-10	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2010083199A1 (fr) *	2009-01-19	2010-07-22	Abbott Laboratories	Inhibiteurs benzthiazole de la poly(adp-ribose)polymérase
GB0905664D0 (en) *	2009-04-02	2009-05-13	Summit Corp Plc	Compounds for treatment of duchenne muscular dystrophy
JP6527851B2 (ja)	2013-03-12	2019-06-05	セルタクシス，インコーポレイテッド	ロイコトリエンａ４加水分解酵素を阻害する方法
EP2968264A4 (fr)	2013-03-14	2016-11-02	Celtaxsys Inc	Inhibiteurs de la leucotriène a4 hydrolase
AU2014239585B2 (en)	2013-03-14	2019-04-04	Celtaxsys, Inc.	Inhibitors of leukotriene A4 hydrolase
AU2014239567B2 (en)	2013-03-14	2017-12-14	Celtaxsys, Inc.	Inhibitors of leukotriene A4 hydrolase
US10045979B2 (en) *	2014-05-19	2018-08-14	Merial Inc.	Anthelmintic compounds
CA3102077A1 (fr)	2018-05-31	2019-12-05	Sanjeev AHUJA	Procede de reduction d'exacerbations pulmonaires chez des patients atteints d'une maladie respiratoire
CN109111376B (zh) *	2018-09-18	2021-09-14	四川医立特生物医药有限公司	一种2,5-双脱氧链霉胺衍生物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5612332A (en) *	1984-03-19	1997-03-18	Alteon Inc.	Di- and triaminoguanidines, and methods of use
JPS6428245A (en)	1987-07-22	1989-01-30	Sumitomo Electric Industries	Production of fluoride glass
MX9202466A (es)	1991-05-24	1994-06-30	Vertex Pharma	Compuestos inmunosupresores novedosos.
CO4520280A1 (es) *	1993-10-26	1997-10-15	Boehringer Ingelheim Pharma	Derivados de pirrolidina, inhibidores de la bioscientesis de leucotrienos
DE19514313A1 (de)	1994-08-03	1996-02-08	Bayer Ag	Benzoxazolyl- und Benzothiazolyloxazolidinone
US5859031A (en)	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) *	1995-06-07	1997-12-09	Gpi Nil Holdings, Inc.	Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5801197A (en) *	1995-10-31	1998-09-01	Gpi Nil Holdings, Inc.	Rotamase enzyme activity inhibitors
US5786378A (en) *	1996-09-25	1998-07-28	Gpi Nil Holdings, Inc.	Heterocyclic thioesters
US5801187A (en) *	1996-09-25	1998-09-01	Gpi-Nil Holdings, Inc.	Heterocyclic esters and amides
US5811434A (en)	1996-11-13	1998-09-22	Vertex Pharmacueticals Incorporated	Methods and compositions for stimulating neurite growth
US5780484A (en)	1996-11-13	1998-07-14	Vertex Pharmaceuticals Incorporated	Methods for stimulating neurite growth with piperidine compounds
US5840736A (en)	1996-11-13	1998-11-24	Vertex Pharmaceuticals Incorporated	Methods and compositions for stimulating neurite growth
US5721256A (en)	1997-02-12	1998-02-24	Gpi Nil Holdings, Inc.	Method of using neurotrophic sulfonamide compounds
GB9815696D0 (en) *	1998-07-20	1998-09-16	Pfizer Ltd	Heterocyclics
GB9815880D0 (en) *	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles

1998
- 1998-07-21 GB GBGB9815880.1A patent/GB9815880D0/en not_active Ceased
1999
- 1999-06-28 CN CNA2003101239079A patent/CN1511837A/zh active Pending
- 1999-06-28 NZ NZ522270A patent/NZ522270A/en unknown
- 1999-06-28 HK HK02100933.8A patent/HK1039779A1/zh unknown
- 1999-06-28 SI SI9930246T patent/SI1100797T1/xx unknown
- 1999-06-28 OA OA1200100023A patent/OA11585A/en unknown
- 1999-06-28 CN CNA2004100399747A patent/CN1611499A/zh active Pending
- 1999-06-28 ID IDW20010155A patent/ID26991A/id unknown
- 1999-06-28 EP EP99963123A patent/EP1100797B1/fr not_active Expired - Lifetime
- 1999-06-28 GE GEAP19995715A patent/GEP20033028B/en unknown
- 1999-06-28 KR KR10-2004-7007852A patent/KR100468185B1/ko not_active Expired - Fee Related
- 1999-06-28 DK DK99963123T patent/DK1100797T3/da active
- 1999-06-28 IL IL14024499A patent/IL140244A0/xx unknown
- 1999-06-28 NZ NZ508838A patent/NZ508838A/xx unknown
- 1999-06-28 CN CNB998089974A patent/CN1174978C/zh not_active Expired - Fee Related
- 1999-06-28 PL PL99345734A patent/PL345734A1/xx not_active Application Discontinuation
- 1999-06-28 EA EA200100052A patent/EA003513B1/ru not_active IP Right Cessation
- 1999-06-28 HR HR20010052A patent/HRP20010052A2/hr not_active Application Discontinuation
- 1999-06-28 HU HU0103413A patent/HUP0103413A3/hu unknown
- 1999-06-28 WO PCT/IB1999/001211 patent/WO2000005232A1/fr not_active Ceased
- 1999-06-28 AU AU42858/99A patent/AU765925B2/en not_active Ceased
- 1999-06-28 AT AT99963123T patent/ATE233261T1/de not_active IP Right Cessation
- 1999-06-28 TR TR2001/00135T patent/TR200100135T2/xx unknown
- 1999-06-28 CA CA002338214A patent/CA2338214C/fr not_active Expired - Fee Related
- 1999-06-28 DE DE69905582T patent/DE69905582T2/de not_active Expired - Fee Related
- 1999-06-28 EE EEP200100044A patent/EE200100044A/xx unknown
- 1999-06-28 BR BR9912330-4A patent/BR9912330A/pt not_active Application Discontinuation
- 1999-06-28 JP JP2000561188A patent/JP3795329B2/ja not_active Expired - Fee Related
- 1999-06-28 KR KR10-2001-7000927A patent/KR100450008B1/ko not_active Expired - Fee Related
- 1999-06-28 ES ES99963123T patent/ES2191484T3/es not_active Expired - Lifetime
- 1999-06-28 AP APAP/P/2001/002046A patent/AP2001002046A0/en unknown
- 1999-06-28 SK SK77-2001A patent/SK772001A3/sk unknown
- 1999-07-07 HN HN1999000106A patent/HN1999000106A/es unknown
- 1999-07-13 TW TW088111868A patent/TWI229672B/zh not_active IP Right Cessation
- 1999-07-19 AR ARP990103544A patent/AR019427A1/es unknown
- 1999-07-19 CO CO99045677A patent/CO5080782A1/es unknown
- 1999-07-20 DZ DZ990151A patent/DZ2851A1/fr active
- 1999-07-20 GT GT199900115A patent/GT199900115A/es unknown
- 1999-07-20 TN TNTNSN99147A patent/TNSN99147A1/fr unknown
- 1999-07-20 MY MYPI99003048A patent/MY118222A/en unknown
- 1999-07-20 CR CR6073A patent/CR6073A/es not_active Application Discontinuation
- 1999-07-20 SV SV1999000102A patent/SV1999000102A/es not_active Application Discontinuation
- 1999-07-20 PE PE1999000727A patent/PE20001037A1/es not_active Application Discontinuation
- 1999-07-20 PA PA19998478501A patent/PA8478501A1/es unknown
- 1999-07-20 MA MA25691A patent/MA24936A1/fr unknown
- 1999-07-21 US US09/358,107 patent/US6372736B1/en not_active Expired - Fee Related
2000
- 2000-12-22 IS IS5790A patent/IS5790A/is unknown
2001
- 2001-01-19 NO NO20010322A patent/NO20010322L/no not_active Application Discontinuation
- 2001-02-14 BG BG105254A patent/BG105254A/xx unknown
2002
- 2002-01-23 US US10/056,901 patent/US6562964B1/en not_active Expired - Fee Related
2003
- 2003-04-09 JP JP2003105099A patent/JP2004002374A/ja active Pending

Also Published As

Publication number	Publication date
HN1999000106A (es)	1999-11-11
EA003513B1 (ru)	2003-06-26
TNSN99147A1 (fr)	2005-11-10
TR200100135T2 (tr)	2001-06-21
PA8478501A1 (es)	2000-05-24
DK1100797T3 (da)	2003-04-22
HUP0103413A3 (en)	2002-10-28
JP3795329B2 (ja)	2006-07-12
EA200100052A1 (ru)	2001-06-25
BG105254A (en)	2001-10-31
IS5790A (is)	2000-12-22
CN1611499A (zh)	2005-05-04
SK772001A3 (en)	2001-12-03
NO20010322L (no)	2001-03-15
GEP20033028B (en)	2003-07-25
NO20010322D0 (no)	2001-01-19
NZ508838A (en)	2002-12-20
KR100468185B1 (ko)	2005-01-26
KR20010071013A (ko)	2001-07-28
AR019427A1 (es)	2002-02-20
KR20040062640A (ko)	2004-07-07
HK1039779A1 (zh)	2002-05-10
PL345734A1 (en)	2002-01-02
CA2338214C (fr)	2006-08-01
SI1100797T1 (en)	2003-06-30
DE69905582T2 (de)	2003-09-04
DZ2851A1 (fr)	2004-02-04
GT199900115A (es)	2001-01-10
GB9815880D0 (en)	1998-09-16
CO5080782A1 (es)	2001-09-25
CR6073A (es)	2004-04-29
US6372736B1 (en)	2002-04-16
KR100450008B1 (ko)	2004-09-24
US6562964B1 (en)	2003-05-13
CN1310718A (zh)	2001-08-29
HUP0103413A2 (hu)	2002-05-29
AU4285899A (en)	2000-02-14
HRP20010052A2 (en)	2001-12-31
BR9912330A (pt)	2001-04-17
ATE233261T1 (de)	2003-03-15
CN1174978C (zh)	2004-11-10
IL140244A0 (en)	2002-02-10
ID26991A (id)	2001-02-22
JP2002521382A (ja)	2002-07-16
CN1511837A (zh)	2004-07-14
AU765925B2 (en)	2003-10-02
MA24936A1 (fr)	2000-04-01
SV1999000102A (es)	2000-07-06
CA2338214A1 (fr)	2000-02-03
AP2001002046A0 (en)	2001-03-31
OA11585A (en)	2004-07-26
EP1100797B1 (fr)	2003-02-26
DE69905582D1 (de)	2003-04-03
EP1100797A1 (fr)	2001-05-23
JP2004002374A (ja)	2004-01-08
NZ522270A (en)	2004-03-26
WO2000005232A1 (fr)	2000-02-03
PE20001037A1 (es)	2000-10-11
ES2191484T3 (es)	2003-09-01
TWI229672B (en)	2005-03-21
MY118222A (en)	2004-09-30

Publication	Publication Date	Title
EE200100044A (et)	2002-06-17	Heterotsüklilised ühendid kui rotamaasensüümide inhibiitorid
DK1060178T3 (da)	2003-11-24	Heterocyklisk forbindelser som inhibitorer af rotamase enzymer
NO20005673D0 (no)	2000-11-10	Heterocykliske inhibitorer av P38
DK1114051T3 (da)	2003-07-14	Inhibitorer for p38
NO992960L (no)	1999-08-17	Substituerte nitrogen-inneholdende heterocykliske forbindelser som inhibitorer for p38 protein-kinase
FI962800A0 (fi)	1996-07-09	Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
NO20006483D0 (no)	2000-12-19	Forbindelser av ustabile dipeptidyl peptidase IV-inhibitorer
EE200000289A (et)	2001-06-15	Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid
NO20013584D0 (no)	2001-07-20	Fremgangsmåte ved boring
NO20014535D0 (no)	2001-09-18	Inhibitorer av IMPDH-enzym
EE200100509A (et)	2002-12-16	Aminopürimidiinid kui sorbitooldehüdrogenaasi inhibiitorid
AU2002331311A1 (en)	2003-04-01	Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
DE69718480D1 (de)	2003-02-20	Heterocyclische metalloprotease inhibitoren
HU9702036D0 (en)	1998-01-28	New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists
DK0923561T3 (da)	2003-02-24	Heterocykliske metalloproteaseinhibitorer
DK1104420T3 (da)	2003-01-13	Substituerede 1,8-naphthyridin-4(1H)-oner som phosphodiesterase-4-inhibitorer
EE200100039A (et)	2002-06-17	Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid
EE200300266A (et)	2003-10-15	Asendatud 8-arüülkinoliinid kui fosfodiesteraas-4inhibiitorid
NO20012832D0 (no)	2001-06-08	Heterocykliske karboksamid-holdige tiourea-inhibitorer for herpesvirus inneholdende fenylendiamingruppe
NO20005301D0 (no)	2000-10-20	Pyrrolidiner som inhibitorer av neuraminidaser